Zhikun Zheng

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Adipose-Derived Exosomes: mediators of crosstalk between Adipose tissue and cancer.

Adipose-Derived Exosomes: mediators of crosstalk between Adipose tissue and cancer.

Journal: Cancer biology & therapy
Published: August 16, 2025

Comment on "Reduced hemoglobin-corrected diffusing capacity in pulmonary arterial hypertension with preserved pulmonary function and morphology".

Comment on "Reduced hemoglobin-corrected diffusing capacity in pulmonary arterial hypertension with preserved pulmonary function and morphology".

Journal: Respiratory investigation
Published: July 30, 2025

CDKL1 potentiates the antitumor efficacy of radioimmunotherapy by binding to transcription factor YBX1 and blocking PD-L1 expression in lung cancer.

CDKL1 potentiates the antitumor efficacy of radioimmunotherapy by binding to transcription factor YBX1 and blocking PD-L1 expression in lung cancer.

Journal: Journal of experimental & clinical cancer research : CR
Published: December 14, 2023

Tumor-associated macrophage-derived exosomes LINC01592 induce the immune escape of esophageal cancer by decreasing MHC-I surface expression.

Tumor-associated macrophage-derived exosomes LINC01592 induce the immune escape of esophageal cancer by decreasing MHC-I surface expression.

Journal: Journal of experimental & clinical cancer research : CR
Published: July 12, 2023

MRPS16 promotes lung adenocarcinoma growth via the PI3K/AKT/Frataxin signalling axis.

MRPS16 promotes lung adenocarcinoma growth via the PI3K/AKT/Frataxin signalling axis.

Journal: Journal of cellular and molecular medicine
Published: June 05, 2023

Arginine methyltransferase PRMT5 methylates and destabilizes Mxi1 to confer radioresistance in non-small cell lung cancer.

Arginine methyltransferase PRMT5 methylates and destabilizes Mxi1 to confer radioresistance in non-small cell lung cancer.

Journal: Cancer letters
Published: December 02, 2021

Corrigendum: LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling.

Corrigendum: LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling.

Journal: Frontiers in oncology
Published: August 16, 2021

UBE3A activates the NOTCH pathway and promotes esophageal cancer progression by degradation of ZNF185.

UBE3A activates the NOTCH pathway and promotes esophageal cancer progression by degradation of ZNF185.

Journal: International journal of biological sciences
Published: March 31, 2021

Monocytes promote pyroptosis of endothelial cells during lung ischemia-reperfusion via IL-1R/NF-κB/NLRP3 signaling.

Monocytes promote pyroptosis of endothelial cells during lung ischemia-reperfusion via IL-1R/NF-κB/NLRP3 signaling.

Journal: Life sciences
Published: November 12, 2020

Prolonged survival time with surgical therapy in different types of thymoma: an analysis based on Surveillance Epidemiology and End Results Database.

Prolonged survival time with surgical therapy in different types of thymoma: an analysis based on Surveillance Epidemiology and End Results Database.

Journal: Translational cancer research
Published: February 10, 2020

LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling.

LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling.

Journal: Frontiers in oncology
Published: December 26, 2019

HDAC3 modulates cancer immunity via increasing PD-L1 expression in pancreatic cancer.

HDAC3 modulates cancer immunity via increasing PD-L1 expression in pancreatic cancer.

Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: September 18, 2018
Showing 1-12 of 15

Last Updated: 09/26/2026